Myanmar Medical Device Directory: FDA Registrations & Distributors

A quantitative analysis of the Myanmar FDA medical device registry, detailing manufacturer country-of-origin distributions, top local distributors, and registration pathways.

Myanmar Medical Device Registry Insights

For global medical device manufacturers targeting the Association of Southeast Asian Nations (ASEAN), navigating individual national registries is essential for market planning, competitor analysis, and local partner selection. The Department of Food and Drug Administration (FDA) under the Ministry of Health of the Republic of the Union of Myanmar maintains the official Medical Device Directory. Analyzing the registry database provides a quantitative view of active registrations, country-of-origin concentrations, and local distribution networks.

An analysis of the Myanmar FDA medical device registry (based on the snapshot compiled on June 21, 2026) reveals:

Total Registered Records: 6,068 active medical product records.
Unique Generic Products: 4,404 unique product generic names.
Unique Local Importers: 286 unique local importer companies holding active registrations.
Leading Legal Countries of Origin: China is the leading legal country of origin, accounting for 1,691 legal manufacturer registrations (27.9% of the registry), followed by the United States with 980 registrations (16.2%), Germany with 809 registrations (13.3%), Korea with 487 registrations (8.0%), and India with 462 registrations (7.6%).
Leading Physical Countries of Origin: China is also the dominant physical manufacturing location, accounting for 1,884 physical manufacturer registrations (31.0% of the registry), reflecting the high volume of global brands outsourcing manufacturing to Chinese facilities.
Local Distributor Concentration: The local importer landscape is highly concentrated. Sea Lion Company Limited leads the market with 600 registrations (9.9% of the directory), followed by Yee Shin Company Limited with 412 registrations (6.8%), A A Medical Products Limited with 364 registrations (6.0%), Okkar Thiri Company Limited with 340 registrations (5.6%), and Zizawa Company Limited with 262 registrations (4.3%). Together, these top 5 local distributors control 1,978 registrations, representing 32.6% of the entire national database.

Understanding these dynamics is critical for selecting local commercial partners and structuring distribution agreements to avoid registry lock-in risks.

Myanmar Medical Device Regulatory Environment

The regulation of medical devices in Myanmar is overseen by the Department of Food and Drug Administration (Myanmar FDA), which operates under the Ministry of Health. The regulatory framework is guided by the National Drug Law (1992) and the newer Myanmar Medical Device Law, which is designed to align with the ASEAN Medical Device Directive (AMDD) standards.

Under the current rules, all medical devices imported into or distributed within Myanmar must be registered with the FDA. The registration process yields a Medical Device Registration Certificate (MDRC), which is typically valid for five years.

Risk Classification under the AMDD Framework

In alignment with the AMDD, Myanmar FDA classifies medical devices into four risk categories based on their vulnerability and invasiveness:

Class A (Low Risk): Non-invasive devices, simple surgical instruments, examination gloves, and basic hospital consumables. These devices face the lowest regulatory hurdles but still require notification.
Class B (Low-Moderate Risk): Hypodermic needles, suction equipment, surgical gloves, and simple diagnostic instruments.
Class C (Moderate-High Risk): Orthopedic implants, anesthesia machines, hemodialysis systems, and complex diagnostic equipment.
Class D (High Risk): Pacemakers, heart valves, coronary stents, implantable active devices, and neurological catheters.

For Class B, C, and D devices, a complete Common Submission Dossier Template (CSDT) must be submitted through the local importer of record. For similar regional analysis of medical device databases, see our Vietnam medical device register analysis which details ASEAN-aligned regulatory pathways.

What is the volume and distribution of medical devices in Myanmar's FDA registry?

The Myanmar FDA Medical Device Directory contains a total of 6,068 registered medical product records. These records do not represent individual shipments, but rather approved registrations held by local Myanmar companies on behalf of domestic and foreign legal manufacturers.

A clean analysis of the dataset shows that these 6,068 records map to 4,404 unique product names. This discrepancy indicates that many generic medical devices (such as syringes, catheters, surgical gloves, or IV administration sets) are registered multiple times by different local importers.

The reasons for this registration redundancy are primarily commercial:

Multi-Channel Distribution: Foreign manufacturers of high-volume consumables often appoint multiple local importers to access different regions or tender networks. Each importer must register the device under their own name, leading to duplicate records in the national database.
Tender-Specific Registrations: Public tenders issued by the Ministry of Health or individual military hospitals often require that the bid be accompanied by an active registration held by the bidding entity. Large distributors will register the same product line multiple times to accommodate different bidding entities or joint ventures.
Portfolio Overlaps: In some cases, a single foreign manufacturer sells similar generic products under different brand names through separate local partners, resulting in multiple distinct registrations for what is functionally the same device.

The 6,068 registrations are split among 286 unique local importer companies. The average local importer holds approximately 21 registrations. However, this average is highly skewed by a small group of dominant distributors. The median number of registrations per company is only 4, indicating a long tail of small importers holding a handful of registrations for specific products, while a few large distributors manage major multi-brand portfolios.

Which manufacturing countries dominate the medical device supply chain to Myanmar?

Understanding where Myanmar imports its medical technology highlights the country's reliance on different foreign supply chains. The database differentiates between the legal manufacturer (the brand owner who holds the legal responsibility for the design and safety of the device) and the physical manufacturer (the actual manufacturing plant where the device is fabricated).

Legal Manufacturer Origins

China is the leading legal country of origin in the registry, representing 27.9% (1,691 registrations) of the database. This reflects a broad push by Chinese manufacturers (such as Sophonix, Deepblue Medical, and Lifotronic) to establish market shares across Southeast Asia, supported by bilateral trade agreements and competitive pricing.

The United States is the second-largest legal origin, holding 16.2% (980 registrations), followed closely by Germany with 13.3% (809 registrations). This shows that Western multinational brands (such as Medtronic, BD, and B. Braun) maintain a strong presence in Myanmar's healthcare sector, particularly for high-risk, clinically complex devices (Class C and D) where safety records and clinical data are heavily scrutinized.

Korea and India represent the fourth and fifth largest legal origins, with 8.0% (487 registrations) and 7.6% (462 registrations) respectively. India primarily supplies lower-cost consumables, disposables, and basic hospital furniture, while Korea supplies diagnostics, imaging systems, and aesthetic devices.

Legal Manufacturer Country of Origin Distribution:
+-------------------+---------+------------+
| Country           | Count   | Percentage |
+-------------------+---------+------------+
| China             | 1,691   | 27.9%      |
| United States     | 980     | 16.2%      |
| Germany           | 809     | 13.3%      |
| South Korea       | 487     | 8.0%       |
| India             | 462     | 7.6%       |
| Japan             | 437     | 7.2%       |
| United Kingdom    | 248     | 4.1%       |
| France            | 154     | 2.5%       |
| Others            | 800     | 13.2%      |
+-------------------+---------+------------+

Physical Manufacturer Origins (The Supply Chain Realities)

When analyzing the physical manufacturer field, China's dominance increases from 27.9% to 31.0% (1,884 registrations). Conversely, physical registrations for the United States and Germany drop compared to their legal registrations.

This gap illustrates global supply chain outsourcing. While a medical device may be legally registered under a US or German corporate entity, the physical product is frequently manufactured in China, Malaysia, or another low-cost manufacturing hub in Asia. For foreign manufacturers, this means the Myanmar FDA requires clear documentation tracing the relationship between the legal brand holder and the contract manufacturing site. Both facilities must possess appropriate Quality Management System (QMS) certifications, such as ISO 13485.

Who are the leading local distributors registered under the Myanmar FDA?

In Myanmar, a foreign manufacturer cannot hold a Medical Device Registration Certificate directly. The registration must be held by a local entity, which serves as the Authorized Representative (AR) / Importer of Record.

The registry shows a high concentration of market power among a few large distributors. The top 5 local importers control 32.6% (1,978 registrations) of the entire database.

Distributor Concentration - Top 5 Local Importers:
+------------------------------------+---------+------------+
| Importer Company Name              | Count   | Percentage |
+------------------------------------+---------+------------+
| SEA LION COMPANY LIMITED           | 600     | 9.9%       |
| YEE SHIN COMPANY LIMITED           | 412     | 6.8%       |
| A A MEDICAL PRODUCTS LIMITED       | 364     | 6.0%       |
| OKKAR THIRI COMPANY LIMITED        | 340     | 5.6%       |
| ZIZAWA COMPANY LIMITED             | 262     | 4.3%       |
| All Other Importers (281 firms)    | 4,090   | 67.4%      |
+------------------------------------+---------+------------+

Profiles of the Dominant Importers

1. Sea Lion Company Limited (600 Registrations)

Sea Lion is the largest distributor in the directory, holding nearly 10% of all active medical device approvals. The company represents major international brands, including GE Healthcare, Medtronic, and BD. Sea Lion's portfolio spans high-end imaging systems, critical care equipment, and surgical instruments. They possess robust engineering capabilities to support hospital installations and servicing.

2. Yee Shin Company Limited (412 Registrations)

Yee Shin is the second-largest player, focusing heavily on IVD reagents, laboratory diagnostics, and clinical consumables. They represent several Chinese and Korean diagnostics companies, providing distribution and technical support across public and private laboratories throughout Yangon and Mandalay.

3. A A Medical Products Limited (364 Registrations)

A A Medical Products (also known as Pacific-AA) is a major pharmaceutical and medical device distributor. Their medical device portfolio focuses on high-volume hospital consumables, surgical sutures, and basic diagnostic equipment, leveraging their extensive pharmacy retail network.

4. Okkar Thiri Company Limited (340 Registrations)

Okkar Thiri is a specialized medical engineering and supply firm. They focus on hospital turnkey projects, supplying operating theater tables, lights, anesthesia systems, and medical gas networks. They are highly active in public healthcare tenders.

5. Zizawa Company Limited (262 Registrations)

Zizawa is a key supplier of medical consumables, wound care products, and orthopedics. They maintain distribution channels serving both public ministry hospitals and private clinics, with a reputation for strong supply chain management under difficult economic conditions.

Step-by-Step Guide to Medical Device Registration in Myanmar

For foreign manufacturers planning to enter the Myanmar market, the registration workflow involves several distinct phases:

Step 1: Appointment of the Local Importer (Authorized Representative)

Because the registration certificate is issued to a local firm, the manufacturer must sign a Letter of Authorization (LoA) appointing a licensed Myanmar importer as their representative. The LoA must be notarized and embassy-legalized.

Step 2: CSDT Dossier Compilation

The manufacturer must compile the technical documentation in accordance with the ASEAN Common Submission Dossier Template (CSDT). The dossier must include:

Executive Summary: Overview of the device, indications for use, risk classification, and commercial history.
Device Description: Technical specifications, engineering drawings, materials list, and software description.
Essential Principles Checklist: Demonstrating how the device complies with the safety and performance requirements of the AMDD.
Risk Analysis: A formal risk management report according to ISO 14971.
Product Verification and Validation: Results of bench testing, biocompatibility testing, electrical safety, electromagnetic compatibility, and software validation.
Clinical Evaluation: Clinical trial data or a literature review justifying the clinical safety of the device.
Manufacturing Information: Description of the manufacturing steps, sterilization processes, and quality system certificates (ISO 13485).

Step 3: Free Sale Certificate (FSC)

The Myanmar FDA requires a Certificate of Free Sale (CFS / FSC) issued by the regulatory authority of the country of origin (e.g., US FDA, EU Notified Body, or national competent authorities). For devices manufactured in third countries, an FSC from a reference jurisdiction (such as Singapore, Australia, or Japan) can help accelerate the review process.

Step 4: Submission and Fee Payment

The local importer submits the CSDT dossier and FSC to the Myanmar FDA. The registration fees are separate from subsequent import permit fees:

Application Review Fee: Typically paid in local currency (Kyat) and varies by risk classification.
Certificate Fee: Paid upon approval of the Medical Device Registration Certificate (MDRC).

Step 5: FDA Review and Clarification

The FDA reviews the technical file. If any documentation is missing or unclear, they will issue a letter of clarification. The manufacturer, through the local importer, typically has 30 to 60 days to respond to these requests.

Step 6: Certificate Issuance and Import Permit

Once approved, the FDA issues the MDRC to the local importer. With this certificate, the importer can apply for an Import Permit for individual commercial shipments.

Public vs. Private Market Dynamics in Myanmar

Entering manufacturers must distinguish between the regulatory and commercial pathways for the public hospital sector and the private healthcare system in Myanmar:

The Public Hospital Sector

Tender Cycles: The Ministry of Health conducts centralized tenders annually for major hospital equipment and high-volume consumables. Bidding requires active registrations, making partner selection critical. Large distributors like Okkar Thiri and Sea Lion have dedicated teams managing these tender submissions.
Funding and Payment: Public procurement is funded by national budgets, though international aid (from organizations like the WHO or ADB) occasionally funds specific programs. Payment is typically in local currency, which introduces exchange rate risks due to Kyat fluctuations.
Regulatory Tolerances: While the CSDT is required, public procurement panels sometimes prioritize cost over brand status, creating opportunities for value-priced brands.

The Private Healthcare System

Commercial Clinics: The private market consists of private hospitals in Yangon, Mandalay, and Taunggyi, alongside specialized outpatient clinics. Private purchases are faster, bypassing centralized annual tender cycles.
Out-of-Pocket Payment: Private healthcare is heavily self-funded by patients. High-end services (such as advanced imaging or elective surgeries) rely on affluent patients, meaning premium brands (US and German legal manufacturers) dominate this space due to perceived quality.
Distributor Networks: The private market relies on distributors who can provide direct sales representation and maintenance services. The top 5 importers have direct sales representatives visiting private clinics daily.

For example, when marketing to private hospitals, the sales cycle operates through direct relationships with procurement committees, clinical department heads, and nursing supervisors. The decision to adopt a new medical device is driven by technical parameters, clinical benefits, and distributor service reputation rather than the lowest price criterion common in public tenders. Because private healthcare represents a significant share of total healthcare spending in Myanmar, manufacturers must balance their pricing strategies to remain competitive in public tenders while capturing higher margins in the private sector.

Risk Management: Preventing Importer Lock-In

Because the Myanmar FDA issues the Medical Device Registration Certificate (MDRC) directly in the name of the local importer, foreign manufacturers face the risk of importer lock-in.

If a manufacturer becomes dissatisfied with their distributor's sales performance or service quality, they cannot easily switch to a new distributor. The registration certificate is legally owned by the local importer. Under Myanmar FDA rules, transferring an MDRC to a new importer requires the written consent of the original certificate holder.

Strategies to Protect Your Market Access

1. Separate Holder from Commercial Distributor

The safest approach is to utilize an independent regulatory consultant or a dedicated third-party logistics (3PL) firm to hold the MDRC. This independent entity does not engage in commercial sales, allowing the manufacturer to appoint multiple commercial distributors who purchase the products under the independent holder's import license.

2. Include a Clear "Letter of Release" Clause in the Contract

If the registration must be held by the commercial distributor, the distribution agreement should include a binding clause requiring the distributor to:

Co-operate with the manufacturer to transfer the registration certificate to a new importer upon termination of the agreement.
Provide a signed Letter of Release within a specified number of days (e.g., 14 days) following termination, without demanding compensation.
Agree that failure to provide the Letter of Release will constitute a material breach of contract, triggering automatic financial penalties and indemnification of the manufacturer's lost sales.

3. Hold the Intellectual Property and Trademarks

Ensure that all brand trademarks and product patents are registered in the manufacturer's name in Myanmar. A distributor who refuses to release a registration certificate cannot sell the product if they do not hold the rights to the trademark, reducing their leverage.

Sample Contractual Clause for Registration Transfer

To assist legal and business development teams, a standard registration transfer protection clause should contain the following elements:

"The Distributor acknowledges that the Medical Device Registration Certificates (MDRCs) obtained in Myanmar are held on behalf of the Manufacturer. Upon expiration or termination of this Agreement for any reason, the Distributor shall, at its own expense, take all necessary steps to transfer the MDRCs to the Manufacturer or to a third party designated by the Manufacturer. 

Specifically, the Distributor shall provide a fully signed and notarized Letter of Release to the Myanmar Department of Food and Drug Administration within fourteen (14) calendar days of receiving a written request from the Manufacturer. 

In the event that the Distributor fails to provide the Letter of Release within the specified period, the Distributor shall pay the Manufacturer a fee of USD 5,000 for each week of delay as liquidated damages, and the Manufacturer reserves the right to pursue all legal remedies to enforce the transfer."

2026 Regulatory Updates and Challenges in Myanmar

The regulatory landscape in Myanmar for 2026 is marked by several challenges related to the broader economic situation:

Banking and Foreign Exchange Restrictions: The Central Bank of Myanmar enforces strict rules on foreign exchange. Local importers must obtain approval to buy US dollars or Euros to pay foreign suppliers, leading to payment delays. Manufacturers should establish clear payment terms (such as Letters of Credit or advance payments) to manage this risk.
Import License Delays: Beyond the FDA's Medical Device Registration Certificate, importers must apply for an Import License from the Ministry of Commerce for each shipment. The processing time for these licenses has increased in 2026 due to import control policies aimed at conserving foreign reserves.
E-Filing Implementation: The Myanmar FDA is moving toward electronic filing systems for renewals and minor variations. While this is intended to speed up review times, technical glitches have occasionally delayed submission processing.
Documentary Scrutiny: Due to the rise of counterfeit medical consumables, the FDA has increased its scrutiny of FSCs and notarized documents. Any discrepancy in names or addresses between the CSDT, the FSC, and the local company registration will result in immediate clarification requests, delaying clearance by several months.

Furthermore, the Ministry of Health has introduced additional documentary requirements for active medical devices, including compliance statements with international electromagnetic safety standards (such as IEC 60601-1) and software life cycle processes (such as IEC 62304). The local authorized representative must submit notarized declaration statements from the legal manufacturer confirming that the software version distributed in Myanmar matches the version validated under the CE marking file. Any discrepancies can trigger technical reviews, delaying the import permit process by several weeks.

Frequently Asked Questions

What regulator oversees medical device registration and the registry in Myanmar?

The regulatory body is the Department of Food and Drug Administration (FDA), which operates under the Ministry of Health (MOH) of the Republic of the Union of Myanmar. The FDA is responsible for evaluating technical dossiers, issuing registration certificates, and monitoring post-market safety.

Who is the leading local importer in the Myanmar FDA medical device directory?

The leading local importer is Sea Lion Company Limited, which holds 600 active registrations (9.9% of the database). Sea Lion represents major global manufacturers, including GE Healthcare, Medtronic, and Becton Dickinson.

How long is a Myanmar Medical Device Registration Certificate valid?

A Medical Device Registration Certificate (MDRC) issued by the Myanmar FDA is typically valid for five years. Renewal applications should be submitted at least six months before the certificate's expiration date to prevent import disruptions.

Are clinical trials in Myanmar required for foreign medical devices?

No. Myanmar FDA does not typically require local clinical trials for foreign medical devices. The FDA accepts clinical data generated in other countries as part of the CSDT dossier, provided the clinical investigation was conducted in accordance with Good Clinical Practice (GCP) and the study population is relevant.

Conclusion: Vetting and Value in the Myanmar Market

Despite geopolitical challenges and currency volatility, Myanmar remains a growing healthcare market with over 54 million residents. The expansion of the FDA directory to over 6,000 active registrations shows that global manufacturers continue to invest in the country.

Because the distributor landscape is highly concentrated—with the top 5 players controlling nearly a third of all registrations—entering manufacturers must perform due diligence when selecting partners. Aligning with an established distributor like Sea Lion, Yee Shin, or Pacific-AA offers regulatory experience and distribution infrastructure, but it also increases the need for robust contract structuring to prevent registration lock-in and secure long-term market access.

References

Myanmar Ministry of Health: Department of Food and Drug Administration Portal. FDA Myanmar
Ministry of Health Myanmar: Official Ministry Web Portal. MOH Myanmar
EuroCham Myanmar Healthcare Guide: Regulatory Summary and Healthcare Sector Overview. EuroCham Myanmar
ASEAN Secretariat: ASEAN Medical Device Directive (AMDD) Framework Agreement.